Romidepsin

Romidepsin is a medication used primarily to treat certain types of cancer, specifically some forms of lymphoma, such as cutaneous T-cell lymphoma. It belongs to a class of drugs called histone deacetylase inhibitors, which work by blocking enzymes that affect how genes are expressed. This action can help to slow down or stop the growth of cancer cells. Romidepsin is typically administered intravenously in a clinical setting and is part of a broader treatment plan, often used when other therapies have not been effective. Like all medications, it can have side effects and requires careful monitoring by healthcare professionals.